Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more
Lupin Limited (LUPIN) - Total Liabilities
Latest total liabilities as of September 2025: ₹137.72 Billion INR
Based on the latest financial reports, Lupin Limited (LUPIN) has total liabilities worth ₹137.72 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lupin Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Lupin Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lupin Limited Competitors by Total Liabilities
The table below lists competitors of Lupin Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Vanke Co. Ltd
PINK:CHVKF
|
USA | $835.24 Billion |
|
Bharat Petroleum Corporation Limited
NSE:BPCL
|
India | ₹1.34 Trillion |
|
MGM China Holdings Ltd
PINK:MCHVY
|
USA | $28.90 Billion |
|
MSA Safety
NYSE:MSA
|
USA | $1.19 Billion |
|
Voya Financial Inc
NYSE:VOYA
|
USA | $171.82 Billion |
|
Prada Spa PK
PINK:PRDSY
|
USA | $4.08 Billion |
|
MarketAxess Holdings Inc
NASDAQ:MKTX
|
USA | $650.35 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Lupin Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lupin Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lupin Limited (2004–2025)
The table below shows the annual total liabilities of Lupin Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹119.11 Billion | +23.76% |
| 2024-03-31 | ₹96.24 Billion | -7.58% |
| 2023-03-31 | ₹104.13 Billion | +8.48% |
| 2022-03-31 | ₹95.99 Billion | -1.57% |
| 2021-03-31 | ₹97.52 Billion | -21.37% |
| 2020-03-31 | ₹124.03 Billion | -12.41% |
| 2019-03-31 | ₹141.60 Billion | +11.60% |
| 2018-03-31 | ₹126.88 Billion | -2.96% |
| 2017-03-31 | ₹130.75 Billion | +14.40% |
| 2016-03-31 | ₹114.29 Billion | +169.59% |
| 2015-03-31 | ₹42.40 Billion | +32.18% |
| 2014-03-31 | ₹32.08 Billion | -12.13% |
| 2013-03-31 | ₹36.50 Billion | -6.33% |
| 2012-03-31 | ₹38.97 Billion | +39.59% |
| 2011-03-31 | ₹27.92 Billion | +12.02% |
| 2010-03-31 | ₹24.92 Billion | -7.53% |
| 2009-03-31 | ₹26.95 Billion | +29.90% |
| 2008-03-31 | ₹20.75 Billion | +49.29% |
| 2007-03-31 | ₹13.90 Billion | -2.06% |
| 2006-03-31 | ₹14.19 Billion | +64.28% |
| 2005-03-31 | ₹8.64 Billion | +8.17% |
| 2004-03-31 | ₹7.98 Billion | -- |